RABAT, Jan. 22 (Xinhua) -- Morocco on Friday approved the emergency use of Chinese Sinopharm COVID-19 vaccine, the Health Ministry said in a statement.
"The vaccine meets all the conditions of quality, efficacy and safety, and does not present any potential side effects," it said.
The first batch of coronavirus vaccines developed by Sinopharm will arrive in Morocco on Jan. 27, the ministry said earlier.
The North African country has secured acquisition of 66 million doses of COVID-19 vaccine from China's Sinopharm and Britain's Oxford University and AstraZeneca. Enditem
